KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
Article in Nature Communications (February 2024)
The most recent citing publications are shown below. View all 79 publications that cite this research output on Dimensions.
Article in Nature Communications (February 2024)
Article in Cancer Research Communications (October 2023)
Article in Proceedings of the National Academy of Sciences of the United States of America (August 2023)